198 related articles for article (PubMed ID: 12187104)
1. Mechanisms and kinetics of Bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents.
Fujigaki Y; Sun DF; Fujimoto T; Suzuki T; Goto T; Yonemura K; Morioka T; Yaoita E; Hishida A
Nephron; 2002 Sep; 92(1):203-12. PubMed ID: 12187104
[TBL] [Abstract][Full Text] [Related]
2. Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats.
Fujigaki Y; Sun DF; Fujimoto T; Yonemura K; Morioka T; Yaoita E; Hishida A
Virchows Arch; 2001 Jul; 439(1):35-45. PubMed ID: 11499838
[TBL] [Abstract][Full Text] [Related]
3. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
Shimizu M; Kondo S; Urushihara M; Takamatsu M; Kanemoto K; Nagata M; Kagami S
Nephrol Dial Transplant; 2006 Sep; 21(9):2380-90. PubMed ID: 16728424
[TBL] [Abstract][Full Text] [Related]
4. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation.
Ng YY; Fan JM; Mu W; Nikolic-Paterson DJ; Yang WC; Huang TP; Atkins RC; Lan HY
Nephrol Dial Transplant; 1999 Dec; 14(12):2860-72. PubMed ID: 10570089
[TBL] [Abstract][Full Text] [Related]
5. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Atkins RC
Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
[TBL] [Abstract][Full Text] [Related]
6. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Mu W; Atkins RC
Clin Exp Immunol; 1997 Nov; 110(2):233-40. PubMed ID: 9367407
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis.
Kanemoto K; Usui J; Tomari S; Yokoi H; Mukoyama M; Aten J; Weening JJ; Nagata M
Lab Invest; 2003 Nov; 83(11):1615-25. PubMed ID: 14615415
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronate is a component of crescents in rat autoimmune glomerulonephritis.
Nishikawa K; Andres G; Bhan AK; McCluskey RT; Collins AB; Stow JL; Stamenkovic I
Lab Invest; 1993 Feb; 68(2):146-53. PubMed ID: 7680079
[TBL] [Abstract][Full Text] [Related]
9. Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis.
Hir ML; Keller C; Eschmann V; Hähnel B; Hosser H; Kriz W
J Am Soc Nephrol; 2001 Oct; 12(10):2060-2071. PubMed ID: 11562404
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical analysis of protein gene product 9.5, a new marker for parietal epithelial cells of Bowman's capsules, in anti-glomerular basement membrane(GBM) antibody induced glomerulonephritis of WKY rats].
Takeda Y; Shirato I; Hayashi K; He JS; Tomino Y
Nihon Jinzo Gakkai Shi; 2001; 43(1):20-7. PubMed ID: 11218314
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against rat podocyte-derived macrophagic cells reacts with crescent-forming cells in an experimental model.
Orikasa M; Iwanaga T; Kawachi H; Oyanagi A; Li P; Su Q; Kobayashi H; Nakayama H; Kikuchi H; Shimizu F
Nephrology (Carlton); 2003 Oct; 8(5):217-23. PubMed ID: 15012707
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis.
Abraham AP; Ma FY; Mulley WR; Nikolic-Paterson DJ; Tesch GH
Nephrology (Carlton); 2018 Feb; 23(2):183-189. PubMed ID: 27862656
[TBL] [Abstract][Full Text] [Related]
14. In situ expression of connective tissue growth factor in human crescentic glomerulonephritis.
Kanemoto K; Usui J; Nitta K; Horita S; Harada A; Koyama A; Aten J; Nagata M
Virchows Arch; 2004 Mar; 444(3):257-63. PubMed ID: 14758550
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Glomerular Sox9
Prochnicki A; Amann K; Wegner M; Sock E; Pfister E; Shankland S; Pippin J; Daniel C
Am J Pathol; 2018 Nov; 188(11):2529-2541. PubMed ID: 30201496
[TBL] [Abstract][Full Text] [Related]
17. The glomerular parietal epithelial cell's responses are influenced by SM22 alpha levels.
Naito S; Pippin JW; Shankland SJ
BMC Nephrol; 2014 Nov; 15():174. PubMed ID: 25376243
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic perspectives for crescentic glomerulonephritis through targeting parietal epithelial cell activation and proliferation.
Huang Y; Zhao X; Zhang Q; Yang X; Hou G; Peng C; Jia M; Zhou L; Yamamoto T; Zheng J
Expert Opin Ther Targets; 2023 Jan; 27(1):55-69. PubMed ID: 36738160
[TBL] [Abstract][Full Text] [Related]
19. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors.
Silva FG; Hoyer JR; Pirani CL
Lab Invest; 1984 Oct; 51(4):404-15. PubMed ID: 6434880
[TBL] [Abstract][Full Text] [Related]
20. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
